Our Corporate Portfolio Strategy service helps pharmaceutical companies optimize their portfolio at the corporate level. We assess therapeutic area mix, pipeline balance, and platform strategies. From diversification decisions to resource reallocation, we help you build a portfolio that maximizes value and manages risk.
How our corporate portfolio strategy service delivers value to your organization.
Comprehensive portfolio assessment including therapeutic area mix, pipeline balance, and risk-return profile.
Therapeutic area diversification strategy to balance risk and opportunity across the portfolio.
Technology platform strategy including platform leverage across multiple assets and indications.
Resource allocation optimization across portfolio assets based on risk-adjusted returns.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Assess current portfolio including assets, therapeutic areas, risk profile, and resource allocation.
Identify portfolio gaps, concentration risks, and diversification opportunities.
Develop portfolio strategy including diversification, platform leverage, and resource allocation.
Establish portfolio governance including review processes and decision criteria.
We assess portfolio risk using probability of success by phase and therapeutic area, concentration analysis, peak sales estimation, time-to-peak analysis, and scenario modeling for pipeline outcomes.
Yes, we develop platform technology strategies that identify how to leverage platforms (e.g., mRNA, antibody, cell therapy) across multiple assets and indications to maximize value.
We use risk-adjusted NPV, probability of success, strategic fit, and opportunity cost to prioritize resource allocation across portfolio assets, ensuring capital goes to highest-value projects.
Corporate-level growth planning, diversification, and new market entry for pharmaceutical companies.
Learn moreProcess optimization, decision framework, and stage-gate redesign for pharmaceutical R&D.
Learn moreData-driven asset valuation and portfolio optimization using clinical, commercial, and regulatory risk scoring.
Learn moreConnect with our team to discuss how our corporate portfolio strategy service can support your goals.
Schedule a Consultation